Fintel reports that on August 9, 2024, Jones Trading initiated coverage of Wave Life Sciences (NasdaqGM:WVE) with a Buy recommendation. As of August 6, 2024, the average one-year price target for ...

Good morning, and welcome to the Wave Life Sciences Second Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded and webcast. I'll now ...

Wave Life Sciences (WVE) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.20 per share a year ago. These ...

Wave Life Sciences Ltd. (NASDAQ:WVE) shareholders are probably feeling a little disappointed, since its shares fell 8.9% to US$5.41 in the week after its latest quarterly results. Revenues were in ...

It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...